Healthcare -
Biotechnology - NASDAQ - US
$ 5.02
1.01 %
$ 284 M
Market Cap
-5.91
P/E
DSGN - TOTAL EQUITY
Total Equity DSGN - Design Therapeutics, Inc.
278 M
LAST VALUE
-14.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR